Emerging Opportunities in Women's Reproductive Health: Market Gaps and Innovations Highlighted in Recent IPO Filing

Investigations reveal that prominent investors are focusing their investments on a cohort of companies dedicated to women’s health, including startups that leverage big data to track fertility and optimize in vitro fertilization (IVF) protocols.

With the aid of technology, women and their families can manage their reproductive behaviors and make important life decisions.

Drawing on data from CB Insights, this article highlights 13 private equity firms that have made significant strides in this increasingly important sector. These startups operate across a diverse range of areas, from biotechnology and the marketing of fertility tracking devices to big-data analytics for assessing in vitro fertilization (IVF) success rates. Prominent investors such as Andreessen Horowitz and Founders Fund have also invested in this space; both participated in the $17 million Series B financing round for Glow, a big-data startup founded by serial entrepreneur Max Levchin.

Next, let’s take a closer look at the detailed profiles of these 13 startups.

Compiled by Chen Xin | Edited by Mo Renying